2024-05-01 16:02 | UU:DERM | | News Release200 | Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer |
2024-04-25 08:31 | UU:DERM | | News Release200 | Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 |
2024-03-21 16:01 | UU:DERM | | News Release200 | Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights |
2024-03-18 08:31 | UU:DERM | | News Release200 | Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea |
2024-03-15 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 |
2024-03-13 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation to Participate in the 36th Annual ROTH Conference |
2024-03-11 08:31 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting |
2024-01-05 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea |
2024-01-02 16:06 | UU:DERM | | News Release200 | Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million |
2023-12-06 08:01 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea |
2023-11-07 16:01 | UU:DERM | | News Release200 | Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights |
2023-11-01 08:00 | UU:DERM | | News Release200 | Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors |
2023-10-31 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 |
2023-10-20 08:31 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn ‚ ® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) |
2023-09-06 08:00 | UU:DERM | | News Release200 | Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza ‚ ® in South Korea and Other Asian Nations |
2023-08-14 16:02 | UU:DERM | | News Release200 | Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights |
2023-08-08 16:02 | UU:DERM | | News Release200 | Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights |
2023-08-02 16:02 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023 |
2023-07-19 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023 |
2023-07-11 08:30 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults |
2023-07-03 08:00 | UU:DERM | | News Release200 | Journey Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of Jul |
2023-06-13 08:31 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects |
2023-05-22 16:02 | UU:DERM | | News Release200 | Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights |
2023-05-19 16:01 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023 |
2023-05-15 16:02 | UU:DERM | | News Release200 | Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights |
2023-05-11 16:01 | UU:DERM | | News Release200 | Journey Medical Corporation Announces Postponement of First Quarter ‚ Financial Results Release and Conference Call |
2023-05-04 09:00 | UU:DERM | | News Release200 | Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023 |